Advances in immunotherapy and targeted therapy of advanced pancreatic cancer
10.3969/j.issn.1005-6483.2023.11.030
- VernacularTitle:晚期胰腺癌免疫治疗与靶向治疗研究进展
- Author:
Xinyi GUO
1
;
Yahong YU
Author Information
1. 430030 武汉,华中科技大学同济医学院附属同济医院胆胰外科
- Keywords:
advanced pancreatic cancer;
targeted therapy;
immunotherapy;
pharmacother-apy
- From:
Journal of Clinical Surgery
2023;31(11):1107-1110
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a highly malignant tumor of the digestive system with poor prognosis.Due to the lack of effective early screening and diagnosis methods,the majority of patients with pancreatic cancer present with locally advanced or metastatic disease at diagnosis.For advanced pancreatic cancer,the major treatment strategy is still chemotherapy-based comprehensive treatment.The development of immunotherapy and targeted therapy gives us cause for optimism in our pursuit of better treatment.This article reviewed the advances in immunotherapy and targeted therapy of advanced pancreatic cancer.
